Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

BACKGROUND: Current tuberculosis treatments leave patients with clinically significant lung injury and increased all-cause mortality post-cure. Adjunctive host-directed therapies could protect the lungs, improve long-term survival, and shorten treatment duration; however, few have been tested clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallis, Robert S, Ginindza, Sibuse, Beattie, Trevor, Arjun, Nishanee, Likoti, Morongwe, Edward, Vinodh A, Rassool, Mohammed, Ahmed, Khatija, Fielding, Katherine, Ahidjo, Bintou A, Vangu, Mboyo D T, Churchyard, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332197/
https://www.ncbi.nlm.nih.gov/pubmed/33740465
http://dx.doi.org/10.1016/S2213-2600(20)30448-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332197/
https://www.ncbi.nlm.nih.gov/pubmed/33740465
http://dx.doi.org/10.1016/S2213-2600(20)30448-3

Ejemplares similares